These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 3509371)

  • 21. Antimicrobial activities of doripenem and other carbapenems against Pseudomonas aeruginosa, other nonfermentative bacilli, and Aeromonas spp.
    Castanheira M; Jones RN; Livermore DM
    Diagn Microbiol Infect Dis; 2009 Apr; 63(4):426-33. PubMed ID: 19249180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Bacteriology of chronic otitis media and the question of sensitivity to antibiotics (author's transl)].
    Decher H; Daum L
    Z Laryngol Rhinol Otol; 1973 Aug; 52(8):583-9. PubMed ID: 4200418
    [No Abstract]   [Full Text] [Related]  

  • 23. Stable carbapenem susceptibility rates among multidrug-resistant Acinetobacter spp. strains in a setting of high prevalence of carbapenem-resistant Pseudomonas aeruginosa.
    Zavascki AP; Soares FC; Superti SV; Silbert S; Silva FM; Barth AL
    Int J Antimicrob Agents; 2007 Aug; 30(2):187-9. PubMed ID: 17452093
    [No Abstract]   [Full Text] [Related]  

  • 24. [Sensitivity of non-fermenting gram-negative rods to antibiotics].
    Ruczkowska J; Dolna I; Przondo-Hessek A; Stankiewicz M
    Wiad Lek; 1984 Dec; 37(24):1934-9. PubMed ID: 6528605
    [No Abstract]   [Full Text] [Related]  

  • 25. In vitro studies of BL-P1462, a new semisynthetic penicillin with anti-pseudomonas activity.
    Barza M; Berman H; Michaeli D; Molavi A; Weinstein L
    Antimicrob Agents Chemother (Bethesda); 1970; 10():341-5. PubMed ID: 5521354
    [No Abstract]   [Full Text] [Related]  

  • 26. In vitro activity of tigecycline against colistin-resistant Acinetobacter spp. isolates from Korea.
    Park YK; Choi JY; Song JH; Ko KS
    Int J Antimicrob Agents; 2009 Mar; 33(3):289-90. PubMed ID: 19091518
    [No Abstract]   [Full Text] [Related]  

  • 27. Ciprofloxacin for selective decontamination of the alimentary tract in patients with acute leukemia during remission induction treatment: the effect on fecal flora.
    Rozenberg-Arska M; Dekker AW; Verhoef J
    J Infect Dis; 1985 Jul; 152(1):104-7. PubMed ID: 3159811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of three standardized disc susceptibility testing methods for colistin.
    Tan TY; Ng LS
    J Antimicrob Chemother; 2006 Oct; 58(4):864-7. PubMed ID: 16905528
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Time for a change? Yes, but not to ciprofloxacin.
    Turnidge J; Christiansen K
    J Paediatr Child Health; 2006 Apr; 42(4):221; author reply 222-3. PubMed ID: 16630328
    [No Abstract]   [Full Text] [Related]  

  • 30. [Non-fermentative gram-negative bacilli: their distribution to clinical materials and antibiotic susceptibility (author's transl)].
    Akalin HE; Baykal M
    Mikrobiyol Bul; 1980 Jan; 14(1):21-6. PubMed ID: 7453583
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [E-test to study small inhibitor concentrations, bacterial diversity and to identify presumptively beta-lactamases in strains of Pseudomonas aeruginosa and Acinetobacter baumannii associated with +nosocomial infections].
    Triantafilo V; Fica A; Silva M; Thompson L
    Rev Med Chil; 1997 Feb; 125(2):149-60. PubMed ID: 9430934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activity of meropenem and comparators against Pseudomonas aeruginosa and Acinetobacter spp. isolated in the MYSTIC Program, 2002-2004.
    Unal S; Garcia-Rodriguez JA
    Diagn Microbiol Infect Dis; 2005 Dec; 53(4):265-71. PubMed ID: 16360550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of adjustment of the pH upon sensitivity of urinary gram-negative bacilli to nine antibiotics.
    Klastersky J; Debusscher L
    Int Z Klin Pharmakol Ther Toxikol; 1971 Apr; 4(3):325-7. PubMed ID: 5579252
    [No Abstract]   [Full Text] [Related]  

  • 34. An in vitro investigation of levofloxacin and ciprofloxacin against clinical isolates of Pseudomonas aeruginosa.
    Segatore B; Perilli M; Larosa M; Setacci D; Celenza G; Amicosante G
    Int J Antimicrob Agents; 2007 Oct; 30(4):374-6. PubMed ID: 17659863
    [No Abstract]   [Full Text] [Related]  

  • 35. In vitro activity of newer broad spectrum beta-lactam antibiotics against enterobacteriaceae and non-fermenters: a report from Austrian intensive care units. Austrian Carbapenem Susceptibility Surveillance Group.
    Krause R; Mittermayer H; Feierl G; Allerberger F; Wendelin I; Hirschl A; Reisinger EC
    Wien Klin Wochenschr; 1999 Jul; 111(14):549-54. PubMed ID: 10467641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Anti-bacterial effect of ofloxacin--in vitro and in vivo results].
    Altay G; Tulunay C
    Mikrobiyol Bul; 1985 Oct; 19(4):183-9. PubMed ID: 3868736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative activity of three new fluoroquinolones.
    Coll R; Esteve M; Moros M; Parés J; Xicota MA
    Chemioterapia; 1987 Jun; 6(2 Suppl):152-3. PubMed ID: 3509374
    [No Abstract]   [Full Text] [Related]  

  • 38. [Role of anaerobic bacteria in the etiopathogenesis of chronic purulent otitis media].
    Camaioni A; Bicciolo G; Croce A
    Acta Otorhinolaryngol Ital; 1987; 7(1):67-75. PubMed ID: 3618205
    [No Abstract]   [Full Text] [Related]  

  • 39. Antimicrobial activity of beta-lactams against multiresistant micro-organisms from the family Enterobacteriaceae, and genus Pseudomonas.
    Niebla A; González I; Vallín C
    Microbios; 1994; 80(325):245-50. PubMed ID: 7700163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimicrobial activity and spectrum of cefoperazone against recent clinical isolates.
    Jones RN; Fuchs PC; Barry AL; Gavan TL; Gerlach EH; Sommers HM
    Clin Ther; 1980; 3(Spec Issue):14-23. PubMed ID: 6446389
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.